AdAlta Limited
AdAlta Limited, a clinical stage biotechnology company, discovers and develops protein therapeutics in Australia. The company's lead i-body drug candidate includes AD-214, which is in Phase I clinical trials for the treatment of idiopathic pulmonary fibr…
Biotechnology
AU, Melbourne [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
AdAlta Limited can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDAdAlta Limited can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of AdAlta Limited.
If you want to see a demo, head over to the financial segments of AAPL